Mumbai, India – March 15, 2017 – In the presence of eminent CIOs, angel investors, industry stalwarts, VCs, and corporate heads, S.L.S Cell Cure Technologies Private Limited has been recognised with HOT 1OO: RACE TO GRACE 2017 Award, which champions innovation and enterprise.
This was the third edition of the Hot 100 Awards, which honour startups providing unique and disruptive technology solutions that work, deliver real benefits, are innovative and potentially address the market at large. This year saw a significant number of entries and the 23 jury member panel was hard pressed to select the winners whose creative use of technology made them stand out. Entries were received from a wide array of fields, from Cloud and Data Analytics to Healthcare, Education, Social Media, eCommerce, IoT, and BFSI, among others.
Winners of the HOT 1OO: RACE TO GRACE 2017 Awards were determined by public voting coupled with scores from an eminent pan-India jury panel. The panel comprised industry stalwarts—CIOs, Investors, Analysts, Commentators and Industry Leaders—who allocated scores and basis their expertise finalised the winners. Selection is made by evaluating the startup’s technological innovation, team strength, opportunity size, and product value proposition. The HOT 100 Awards are a celebration of the entrepreneurial spirit, and seek to recognise and reward India’s most dynamic enterprise-focused startup businesses. Having earned this validation and honour, startups have a platform through which they can introduce their company to the world.
HOT 1OO: RACE TO GRACE 2017 Awards were presented to 100 innovative startups.
“Through the Hot100 Awards we have curate the most validated, trustworthy and promising technology startups in the country,” said Anoop Mathur, Founder & President, Centre Of Recognition & Excellence. “This is done with the help of the CIO community, Angel Investors and the ICT Ecosystem Mentors. I’m very excited for the winners who demonstrated innovation and excellence, with outstanding achievements. I congratulate them on winning this elite tag.”
S.L.S Cell Cure Technologies Pvt Ltd is a startup having its verticals in Molecular Diagnostics with the novelty in Predictive Diagnostics, and the second vertical being Stem Cell Research. The Hot 100 award was conferred to S.L.S’s new platform technology based on ‘Low Cost POC based LAMP Panel’ to detect species specific dengue in low resource settings. This technology platform was innovated on the concept of ‘Lab to Bedside’, instead of bringing the patient sample to central lab, performing the test and sending the report, the lab was taken to the patient’s bedside, so that the clinician has a real-time result, without any sophisticated equipment (except a water bath/heating block) or highly skilled manpower, the result being visual as the positive tube will develop colour, a disruptive technology. The company is looking for investments to the tune of Rs 2 crore to expand its footprint in India to offer these tests in about six other infectious diseases including TB, HIV, etc. S.L.S has already developed the prototypes and is in the advanced stage of validating these panels, which can detect up to species level and drug resistance species.
“The Hot 100 Awards will really have a great positive impact on our endeavour to develop and offer cost affective, high end molecular tests to the patient community, in line with our company’s mission, vision and objectives to exploit these high end technologies to improve patient’s quality of life,” says Dr Shivraj Dasari, Founder and Managing Director, S.L.S Cell Cure Technologies Private Limited.
KPMG is the knowledge partner for HOT 100 2017.
For more information, press only:
Dr Shivraj Dasari, Managing Director
S.L.S. Cell Cure Technologies Private Limited
#103, Prabhat apartments, Street No.11,
East Marredpally, Secunderabad-500026,
Categories: Press Releases